These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1050 related articles for article (PubMed ID: 18783877)

  • 1. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
    Johansson E; Bill-Axelson A; Holmberg L; Onelöv E; Johansson JE; Steineck G;
    Eur Urol; 2009 Feb; 55(2):422-30. PubMed ID: 18783877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
    Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial comment on: Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
    Korfage IJ
    Eur Urol; 2009 Feb; 55(2):432. PubMed ID: 18783875
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment on: Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
    Gattellari M; Ward JE
    Eur Urol; 2009 Feb; 55(2):431. PubMed ID: 18783873
    [No Abstract]   [Full Text] [Related]  

  • 5. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life after radical prostatectomy or watchful waiting.
    Steineck G; Helgesen F; Adolfsson J; Dickman PW; Johansson JE; Norlén BJ; Holmberg L;
    N Engl J Med; 2002 Sep; 347(11):790-6. PubMed ID: 12226149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer.
    Holmberg L; Bill-Axelson A; Helgesen F; Salo JO; Folmerz P; Häggman M; Andersson SO; Spångberg A; Busch C; Nordling S; Palmgren J; Adami HO; Johansson JE; Norlén BJ;
    N Engl J Med; 2002 Sep; 347(11):781-9. PubMed ID: 12226148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial.
    Bill-Axelson A; Garmo H; Holmberg L; Johansson JE; Adami HO; Steineck G; Johansson E; Rider JR
    Eur Urol; 2013 Dec; 64(6):920-8. PubMed ID: 23465517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer.
    Bacon CG; Giovannucci E; Testa M; Kawachi I
    J Urol; 2001 Nov; 166(5):1804-10. PubMed ID: 11586228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical prostatectomy versus watchful waiting in early prostate cancer.
    Bill-Axelson A; Holmberg L; Ruutu M; Häggman M; Andersson SO; Bratell S; Spångberg A; Busch C; Nordling S; Garmo H; Palmgren J; Adami HO; Norlén BJ; Johansson JE;
    N Engl J Med; 2005 May; 352(19):1977-84. PubMed ID: 15888698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy.
    Di Lorenzo G; Perdonà S; De Placido S; D'Armiento M; Gallo A; Damiano R; Pingitore D; Gallo L; De Sio M; Autorino R
    J Urol; 2005 Dec; 174(6):2197-203. PubMed ID: 16280763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
    Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
    J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
    Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted-cryosurgical ablation of the prostate with androgen deprivation therapy: quality of life in high-risk prostate cancer patients.
    Kang SH; Kim JW; Bae JH; Park HS; Moon DG; Yoon DK; Cheon J; Kim JJ
    Asian J Androl; 2006 Sep; 8(5):629-36. PubMed ID: 16847531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mental health in men treated for early stage prostate carcinoma: a posttreatment, longitudinal quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor.
    Litwin MS; Lubeck DP; Spitalny GM; Henning JM; Carroll PR
    Cancer; 2002 Jul; 95(1):54-60. PubMed ID: 12115317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate.
    Wasson JH; Reda DJ; Bruskewitz RC; Elinson J; Keller AM; Henderson WG
    N Engl J Med; 1995 Jan; 332(2):75-9. PubMed ID: 7527493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in Japanese men with localized prostate cancer: assessment with the SF-8.
    Sugimoto M; Takegami M; Suzukamo Y; Fukuhara S; Kakehi Y
    Int J Urol; 2008 Jun; 15(6):524-8. PubMed ID: 18422571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma.
    Fowler FJ; McNaughton Collins M; Walker Corkery E; Elliott DB; Barry MJ
    Cancer; 2002 Jul; 95(2):287-95. PubMed ID: 12124828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer.
    Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
    Urology; 2004 Apr; 63(4):751-6. PubMed ID: 15072894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Bill-Axelson A;
    Eur Urol Oncol; 2018 Jun; 1(2):134-142. PubMed ID: 31100237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.